Login
← Go Back
Panacea Biotec
PANACEABIO · Pharma > Pharmaceuticals & Drugs · Chairman: Soshil Kumar Jain · MD: Rajesh Jain · Listing date: April 18, 1996 · Employees: 2473 · New Delhi · http://www.panaceabiotec.com
Stock Price vs Company Growth
1d
4.7%
1w
4.6%
1m
9.3%
3m
12.7%
6m
23.3%
1y
26.9%
5y
6.6%
10y
14.2%
all
0.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 347 4.7%
293
402
Company Overview
Sales
606 Cr
Growth: 3.8%
Profit after Tax
-52.3 Cr
Growth: 1.0%
Small Cap
2,124 Cr
P/S: 3.5x
Industry P/S: 2.4x
Fundamentals
Sales (Cr) ₹ 606
Growth 3.8%
EBITDA -5.6%
P/S 3.5x
Dividend 0.0%
P/E -273.0x
Book Value ₹ 133
PEG Ratio -72.2x
ROE -6.4%
P/B 2.6x
Shareholding Pattern
Institutions
Serum Institute Of India Pvt Ltd
8.59 %
Promoters
Dr. Rajesh Jain
41.17 %
Sandeep Jain
16.38 %
Soshil Kumar Jain
8.16 %
Nirmala Jain
4.1 %
First Lucre Partnership Co.
3.68 %
Others
Ifpf
0.18 %
Increase    Decrease    No change
Company Profile Detailed
The company has product portfolio that’s caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal.Panacea Biotec is the third largest biotechnology company (as per ABLE Survey, 2006), as well as among the top 50 pharmaceutical companies (as per ORG IMS July 2006) of India.The company has been granted patents across countries like USA, U.K.
Belongs to (4 Indices)
Investors (49)
deposito...
icici.pr...
sunanda....
Followers (5)
bhaskar6
zest
piresh